review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Kaufmann H | |
Caro S | |||
Morgello S | |||
Hague K | |||
Lento P | |||
P433 | issue | 2 | |
P304 | page(s) | 192-196 | |
P577 | publication date | 1997-08-01 | |
P1433 | published in | Acta Neuropathologica | Q343168 |
P1476 | title | The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature | |
P478 | volume | 94 |
Q33158615 | 33-year-old male patient with recurrent syncopes and orthostatic hypotension |
Q39273442 | A case series of REM sleep behavior disorder in pure autonomic failure |
Q34370035 | Afferent baroreflex failure in familial dysautonomia |
Q39012982 | An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease |
Q92365653 | Autonomic Nervous System Dysfunction: JACC Focus Seminar |
Q34004288 | Autonomic disorders predicting Parkinson's disease |
Q82029384 | Autonomic dysfunction in Parkinson's disease |
Q89767194 | Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy |
Q36266543 | Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests |
Q93192834 | Brain-First versus Gut-First Parkinson's Disease: A Hypothesis |
Q48715546 | Brainstem-type Lewy body disease presenting with progressive autonomic failure and lethargy |
Q99566885 | Cardiac sympathetic innervation and vesicular storage in pure autonomic failure |
Q33154162 | Carotid sinus hypersensitivity associated with focal alpha-synucleinopathy of the autonomic nervous system |
Q46685407 | Central dopamine deficiency in pure autonomic failure |
Q37357582 | Chewing-induced hypertension in afferent baroreflex failure: a sympathetic response? |
Q33166368 | Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease. |
Q42527156 | Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease |
Q34264188 | Clinical overview of the synucleinopathies |
Q36011221 | Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. |
Q47377298 | Does sympathetic dysfunction occur before denervation in pure autonomic failure? |
Q34122222 | Drug treatment of non-motor symptoms in Parkinson's disease |
Q34463831 | Dysautonomia in Parkinson disease |
Q35565719 | Dysautonomia in Parkinson's disease: neurocardiological abnormalities |
Q37810586 | Flexible Nets of Malleable Guardians: Intrinsically Disordered Chaperones in Neurodegenerative Diseases |
Q48433149 | Frequent nocturnal vocalization in pure autonomic failure |
Q37155131 | Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension |
Q34742297 | Hypertension in orthostatic hypotension and autonomic dysfunction |
Q35142854 | Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases |
Q37119752 | L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. |
Q45055444 | Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies. |
Q47921420 | Living with autonomic failure |
Q47891351 | MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine |
Q38026735 | Management approaches to hypertension in autonomic failure |
Q48308239 | Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders |
Q73824893 | Multiple system atrophy: new developments in pathophysiology and therapy |
Q37662455 | Natural history of pure autonomic failure: A United States prospective cohort |
Q42108095 | Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease |
Q47649279 | Neuropathology of autonomic dysfunction in synucleinopathies |
Q48551100 | Noise-induced compensation for postural hypotension in primary autonomic failure |
Q37677194 | Non-motor extranigral signs and symptoms in Parkinson's disease |
Q36193915 | Olfaction in Parkinson's disease and related disorders |
Q34182840 | Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases |
Q55339954 | Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithm. |
Q82548341 | Orthostatic hypotension as an early finding in Parkinson's disease |
Q34706775 | Parkinson's disease: a dual-hit hypothesis |
Q39096323 | Precision medicine for disease modification in Parkinson disease |
Q48420703 | Prevalence of anti-locus coeruleus immunoreactivity in CSF of patients with autonomic failure |
Q45067403 | Primary Sjogren's syndrome presenting with generalized autonomic failure |
Q33152820 | Progression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy. |
Q27322513 | Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies |
Q90082554 | Pure Autonomic Failure |
Q51685133 | Pure Autonomic Failure. |
Q73276410 | Pure autonomic failure in association with human alpha-synucleinopathy |
Q53479855 | Pure autonomic failure without alpha-synuclein pathology: an evolving understanding of a heterogeneous disease. |
Q48313756 | Pure autonomic failure without synucleinopathy |
Q54161356 | Pure autonomic failure: Predictors of conversion to clinical CNS involvement. |
Q53126293 | Reduction of Small Fibers of Thoracic Ventral Roots and Neurons of Intermediolateral Nucleus in Parkinson Disease and Dementia with Lewy Bodies. |
Q38740457 | Studying the pathophysiologic connection between cardiovascular and nervous systems using stem cells |
Q33149084 | Syncope and orthostatic intolerance |
Q33151320 | Syncope and orthostatic intolerance for the primary care physician |
Q83505701 | The spectrum of clinicopathological features in pure autonomic neuropathy |
Q64978755 | Very late-onset pure autonomic failure. |
Search more.